Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$0.12
$0.16
$1.57
$763K4.024,068 shs254 shs
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
$11.02
-7.2%
$0.00
$1.22
$63,000.00
$441K-0.03771 shs1.13 million shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.08
-6.9%
$0.08
$0.06
$0.29
$870K0.57,689 shs131 shs
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
$0.78
-5.4%
$1.44
$1.38
$17.04
$517K2.0353,151 shs176,733 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%0.00%0.00%-99.40%-99.81%
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
+4.67%-3.02%-22.62%+2.42%+47.09%
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%-7.07%-8.24%+2.44%-51.65%
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
0.00%-4.21%-40.78%-57.84%+77,579,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00
N/AN/AN/A
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
0.00
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
3.00
Buy$24.002,993.58% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$80K0.00N/AN/A($2.43) per share0.00
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
$3.41M0.13N/AN/A($1,036.00) per share-0.01
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.03N/AN/A$0.57 per share0.14
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
$6.23M0.08N/AN/A($2.06) per share-0.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
-$6.98MN/A0.00N/AN/A-8,257.70%N/A-730.22%8/18/2025 (Estimated)
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
-$19.22MN/A0.00N/A-1,546.38%N/A-343.56%N/A
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%9/22/2025 (Estimated)
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
-$8.03MN/A0.00N/A-119.91%N/A-41.72%8/12/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A
0.10
0.01
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
N/A
0.53
0.50
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
N/A
0.23
0.20

Institutional Ownership

CompanyInstitutional Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
6.91%
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
0.16%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
12.02%

Insider Ownership

CompanyInsider Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
4.50%
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
4.20%
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
1.79%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
104.74 million4.53 millionNot Optionable
Delcath Systems, Inc. stock logo
DCTHD
Delcath Systems
N/A40,000N/ANot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
NAYA Biosciences, Inc. stock logo
NAYA
NAYA Biosciences
10666,0004.40 millionN/A

Media Sentiment Over Time

Top Headlines

View All Headlines
Arch Therapeutics stock logo

Arch Therapeutics OTCMKTS:ARTH

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

Delcath Systems stock logo

Delcath Systems OTCMKTS:DCTHD

Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.08 -0.01 (-6.93%)
As of 09:44 AM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

NAYA Biosciences stock logo

NAYA Biosciences NASDAQ:NAYA

$0.78 -0.04 (-5.39%)
As of 07/11/2025

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.